CXCL1 stimulates migration and invasion in ER‑negative breast cancer cells via activation of the ERK/MMP2/9 signaling axis
Chengcheng Yang(First Affiliated Hospital of Xi'an Jiaotong University), Shengchun Liu(The Affiliated Yongchuan Hospital of Chongqing Medical University)
Cited by 76
Related Papers
Acquired CDK6 amplification promotes breast cancer resistance to CDK4/6 inhibitors and loss of ER signaling and dependence
|Oncogene|2016|430
Sulfasalazine‑induced ferroptosis in breast cancer cells is reduced by the inhibitory effect of estrogen receptor on the transferrin receptor
|Oncology Reports|2019|223
HORMAD1 promotes docetaxel resistance in triple negative breast cancer by enhancing DNA damage tolerance
|Oncology Reports|2021|30
Although c‑MYC contributes to tamoxifen resistance, it improves cisplatin sensitivity in ER‑positive breast cancer
|International Journal of Oncology|2020|24
GBP2 enhances paclitaxel sensitivity in triple‑negative breast cancer by promoting autophagy in combination with ATG2 and inhibiting the PI3K/AKT/mTOR pathway
|International Journal of Oncology|2024|20